- Claritev's PHCS Network secures its 12th consecutive NCQA Accreditation in Credentialing.
- The network remains the only national independent primary PPO with this recognition.
- NCQA Accreditation is valid through June 13, 2028, reaffirming commitment to healthcare quality.
Claritev Corporation (CTEV, Financial) has announced that its PHCS Network, the largest primary Preferred Provider Organization (PPO) in the United States, has received its 12th consecutive Accreditation in Credentialing from the National Committee for Quality Assurance (NCQA). This milestone affirms the PHCS Network's position as the only independently contracted national primary PPO to earn this distinction, showcasing its dedication to the precise and efficient credentialing of healthcare professionals.
Initially accredited in 2001, the PHCS Network successfully navigated an exhaustive review process, maintaining its NCQA Accreditation in Credentialing for the maximum duration of three years, effective until June 13, 2028. The NCQA audit highlighted the network's dedicated staff, well-prepared file reviews, and timely credentialing decisions. According to Jerry Hogge, COO of Claritev, the ongoing accreditation underscores the team's commitment to maintaining high credentialing standards, which supports enhanced patient outcomes nationwide.
The PHCS Network is a vital component of healthcare delivery in the U.S., offering health plan members seamless access to over a million practitioners, 4,600 acute care facilities, and 92,000 ancillary services across the nation. The network's extensive reach and quality assurance initiatives play a crucial role in promoting effective healthcare delivery and improving patient outcomes.
Claritev, formerly known as MultiPlan, is a leading healthcare technology company focused on providing innovative solutions that enhance affordability, transparency, and quality in healthcare. Leveraging over 40 years of experience in claims repricing, Claritev aims to make healthcare more accessible and affordable through cutting-edge data and insights.